- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
- 10-Q Quarterly report
- 15.1 Letter Regarding Unaudited Interim Financial Information
- 31.1 Chief Executive Officer Certification Pursuant to Rule 13A-14(A)
- 31.2 Chief Financial Officer Certification Pursuant to Rule 13A-14(A)
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
Exhibit 15.1
February 7, 2012
Securities and Exchange Commission
100 F Street, N.E.
N.W. Washington, D.C. 20549
Commissioners:
We are aware that our report dated February 7, 2012 on our review of interim financial information of Varian Medical Systems, Inc. for the three-month periods ended December 30, 2011 and December 31, 2010 and included in the Company’s quarterly report on Form 10-Q for the quarter ended December 30, 2011 is incorporated by reference in its Registration Statements on Form S-8 (No. 333-168444, No. 333-168443, No. 333-146176, No. 333-130001, No. 333-152903, No. 333-123778, No. 333-75531, No. 333-57006, No. 333-57008, No. 333-57010, No. 333-57012 and No. 333-161307).
Yours very truly,
/S/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP